Evidence map›Paper›PMID 28193701›Full record

ArticleThe Journal of cell biology2017

Osteoblastic Lrp4 promotes osteoclastogenesis by regulating ATP release and adenosine-A

Lei Xiong, Ji-Ung Jung, Hao-Han Guo, Jin-Xiu Pan, Xiang-Dong Sun, Lin Mei, Wen-Cheng Xiong

Abstract read
In one paragraph

Article in The Journal of cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lei XiongDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912.
Ji-Ung JungDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912.
Hao-Han GuoDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912.
Jin-Xiu PanDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912.
Xiang-Dong SunDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912.
Lin MeiDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912 lmei@augusta.edu wxiong@augusta.edu.
Wen-Cheng XiongDepartment of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta, GA 30912 lmei@augusta.edu wxiong@augusta.edu.ORCID 0000-0001-9071-7598
Augusta University · US

Funding

APP as a common denominator for Alzheimer's disease and osteoporosisR01AG051773 · NIA · CASE WESTERN RESERVE UNIVERSITY · PI XIONG, WEN-CHENG · 2016 to 2020
$2.0M
APPswe as a risk factor for osteoporosisI01BX000838 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI XIONG, WEN-CHENG · 2011 to 2021
–
BLRD VA I01 BX000838NIA NIH HHS R01 AG051773
6 · The paper itself

Abstract

Bone homeostasis depends on the functional balance of osteoblasts (OBs) and osteoclasts (OCs). Lrp4 is a transmembrane protein that is mutated in patients with high bone mass. Loss of Lrp4 in OB-lineage cells increases bone mass by elevating bone formation by OBs and reducing bone resorption by OCs. However, it is unclear how Lrp4 deficiency in OBs impairs osteoclastogenesis. Here, we provide evidence that loss of Lrp4 in the OB lineage stabilizes the prorenin receptor (PRR) and increases PRR/V-ATPase-driven ATP release, thereby enhancing the production of the ATP derivative adenosine. Both pharmacological and genetic inhibition of adenosine-

Indexed as

3T3 CellsAdenosine TriphosphateAnimalsBone and BonesBone ResorptionCell DifferentiationCell LineCell LineageHEK293 CellsHumansLDL-Receptor Related ProteinsMiceOsteoblastsOsteoclastsOsteogenesisOsteoprotegerinAdenosine TriphosphateLDL-Receptor Related ProteinsOsteoprotegerinRANK LigandReceptor Activator of Nuclear Factor-kappa BReceptor, Adenosine A2A

Identifiers

PMID28193701
PMCPMC5350517
OpenAlexW2588668527

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.